BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 25450280)

  • 1. Analysis of hepatocellular carcinoma and metastatic hepatic carcinoma via functional modules in a protein-protein interaction network.
    Pan J; Cong Z; Zhong M; Sun Y
    J Cancer Res Ther; 2014 Nov; 10 Suppl():C186-94. PubMed ID: 25450280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses.
    Wan Z; Zhang X; Luo Y; Zhao B
    Genet Test Mol Biomarkers; 2019 Nov; 23(11):766-777. PubMed ID: 31633428
    [No Abstract]   [Full Text] [Related]  

  • 3.
    Sun Y; Zhang Z
    Genet Test Mol Biomarkers; 2020 May; 24(5):296-308. PubMed ID: 32384023
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioinformatics identification of crucial genes and pathways associated with hepatocellular carcinoma.
    Gao X; Wang X; Zhang S
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30341252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical genes of hepatocellular carcinoma revealed by network and module analysis of RNA-seq data.
    Yang MR; Zhang Y; Wu XX; Chen W
    Eur Rev Med Pharmacol Sci; 2016 Oct; 20(20):4248-4256. PubMed ID: 27831650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma.
    Sang L; Wang XM; Xu DY; Zhao WJ
    World J Gastroenterol; 2018 Jun; 24(24):2605-2616. PubMed ID: 29962817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatic Analysis to Identify a Multi-mRNA Signature for the Prediction of Metastasis in Hepatocellular Carcinoma.
    Liu L; Wang B; Han Q; Zhen C; Li J; Qu X; Wang F; Kong X; Zheng L
    DNA Cell Biol; 2020 Nov; 39(11):2028-2039. PubMed ID: 33147069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of melanoma biomarkers based on network modules by integrating the human signaling network with microarrays.
    Huang C; Sheng Y; Jia J; Chen L
    J Cancer Res Ther; 2014 Nov; 10 Suppl():C114-24. PubMed ID: 25450268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of typical miRNAs and target genes in hepatocellular carcinoma by DNA microarray technique.
    He TL; Zheng KL; Li G; Song B; Zhang YJ
    Eur Rev Med Pharmacol Sci; 2014; 18(1):108-16. PubMed ID: 24452951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying potential drug targets in hepatocellular carcinoma based on network analysis and one-class support vector machine.
    Tong Z; Zhou Y; Wang J
    Sci Rep; 2019 Jul; 9(1):10442. PubMed ID: 31320657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of hepatocellular carcinoma-associated hub genes and pathways by integrated microarray analysis.
    Liu F; Li H; Chang H; Wang J; Lu J
    Tumori; 2015; 101(2):206-14. PubMed ID: 25768320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics analysis to identify the key genes affecting the progression and prognosis of hepatocellular carcinoma.
    Zhang Y; Wang S; Xiao J; Zhou H
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30705088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying significant pathways of hepatitis B virus-related hepatocellular carcinoma based on crosstalk and network pathways.
    Wen LM; Wu WZ; Peng XC
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27420970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of MicroRNAs and target genes involvement in hepatocellular carcinoma with microarray data.
    Wang D; Tan J; Xu Y; Tan X; Han M; Tu Y; Zhu Z; Zen J; Dou C; Cai S
    Hepatogastroenterology; 2015; 62(138):378-82. PubMed ID: 25916067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of dysfunctional biological pathways and their synergistic mechanism in hepatocellular carcinoma process.
    Liang J; Lv J; Liu Z
    Exp Mol Pathol; 2015 Jun; 98(3):540-5. PubMed ID: 25805103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of hepatocellular carcinoma and cirrhosis gene expression profiles.
    Jiang M; Zeng Q; Dai S; Liang H; Dai F; Xie X; Lu K; Gao C
    Mol Med Rep; 2017 Jan; 15(1):380-386. PubMed ID: 27959423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network-based co-expression analysis for exploring the potential diagnostic biomarkers of metastatic melanoma.
    Wang LX; Li Y; Chen GZ
    PLoS One; 2018; 13(1):e0190447. PubMed ID: 29377892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic protein interaction modules in human hepatocellular carcinoma progression.
    Yu H; Lin CC; Li YY; Zhao Z
    BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S2. PubMed ID: 24564909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood gene signature for early hepatocellular carcinoma detection in patients with chronic hepatitis B.
    Omar H; Lim CR; Chao S; Lee MM; Bong CW; Ooi EJ; Yu CG; Tan SS; Abu Hassan MR; Menon J; Muthukaruppan R; Singh M; Nik Abdullah NA; Ooi BP; Ding RP; Low EJ; Tan F; Novak D; Harris DF; Yang H; Merican I; Liew CC
    J Clin Gastroenterol; 2015 Feb; 49(2):150-7. PubMed ID: 25569223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying Biomarkers of Hepatocellular Carcinoma Based on Gene Co-Expression Network from High-Throughput Data.
    Zhang Y; Liu Z; Li JS
    Stud Health Technol Inform; 2017; 245():667-671. PubMed ID: 29295180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.